Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
Blanco, B., Prado, V., Lence, E., Otero, J.M., Garcia-Doval, C., van Raaij, M.J., Llamas-Saiz, A.L., Lamb, H., Hawkins, A.R., Gonzalez-Bello, C.(2013) J Am Chem Soc 135: 12366-12376
- PubMed: 23889343 
- DOI: 10.1021/ja405853p
- Primary Citation of Related Structures:  
4BQS - PubMed Abstract: 
Shikimate kinase (SK) is an essential enzyme in several pathogenic bacteria and does not have any counterpart in human cells, thus making it an attractive target for the development of new antibiotics. The key interactions of the substrate and product binding and the enzyme movements that are essential for catalytic turnover of the Mycobacterium tuberculosis shikimate kinase enzyme (Mt-SK) have been investigated by structural and computational studies ...